Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 8
Submit an article Journal homepage
133
Views
5
CrossRef citations to date
0
Altmetric
Original Scientific Papers

The effect of prior COVID-19 infection on coronary microvascular dysfunction

Önder Bilgea Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8214-972X
ORCID Icon,
Murat Çapa Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0003-1164-2124
ORCID Icon,
Ferat Kepenekb Department of Nuclear Medicine, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0002-5631-7643
ORCID Icon,
Emrah Erdoganc Department of Cardiology, Yüzüncü Yıl University Faculty of Medicine, Van, TurkeyORCID Iconhttps://orcid.org/0000-0003-2329-6310
ORCID Icon,
İsmail Tatlıa Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0002-9800-2105
ORCID Icon,
Cansu Öztürka Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0003-0547-6510
ORCID Icon,
Ercan Taştana Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0002-4896-6993
ORCID Icon,
Cihan Gündoğanb Department of Nuclear Medicine, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0001-5700-6292
ORCID Icon,
Ferhat Işıka Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0002-1438-3327
ORCID Icon,
Metin Okşula Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0003-0531-3500
ORCID Icon,
Mesut Oktaya Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey
,
Halil Akınd Department of Cardiology, Private Medicalpark Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-6651-7403
ORCID Icon,
Cengiz Buraka Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0003-2730-0161
ORCID Icon,
Mehmet Zülküf Karahana Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0001-8145-9574
ORCID Icon,
Halil Kömekb Department of Nuclear Medicine, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, TurkeyORCID Iconhttps://orcid.org/0000-0001-8168-136X
ORCID Icon &
İbrahim Halil Tanboğae Department of Biostatistics and Cardiology, Nişantaşı University Faculty of Medicine, İstanbul, TurkeyORCID Iconhttps://orcid.org/0000-0003-4546-9227
ORCID Icon show all
Pages 693-698 | Received 05 Dec 2021, Accepted 12 Apr 2022, Published online: 22 Apr 2022

References

  • Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106(15):1132–1141.
  • World Health Organization. Director-General’s opening remarks at the media briefing on COVID-19; 24 February 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19–-24-february-2020.
  • Duan J, Wu Y, Liu C, et al. Deleterious effects of viral pneumonia on cardiovascular system. Eur Heart J. 2020;41(19):1833–1838.
  • Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418.
  • Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020;142(17):1609–1611.
  • Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879–888.
  • Umman B, Nisanci Y, Sezer M, et al. The relationship between corrected TIMI frame count and myocardial fractional flow reserve. J Invasive Cardiol. 2002;14(3):125–128.
  • Lee S, Otsuji Y, Minagoe S, et al. Correlation between distal left anterior descending artery flow velocity by transthoracic Doppler echocardiography and corrected TIMI frame count before mechanical reperfusion in patients with anterior acute myocardial infarction. Circ J. 2005;69(9):1022–1028.
  • Mavrogeni SI, Manginas A, Papadakis E, et al. Coronary flow evaluation by TIMI frame count and magnetic resonance flow velocity in patients with coronary artery ectasia. J Cardiovas Magn Resonance. 2005;7(3):545–550.
  • Ozdemir N, Kaymaz C, Kirma C, et al. Intravascular ultrasound correlates of corrected TIMI framecount. Jpn Heart J. 2003;44(2):213–224.
  • Turhan H, Erbay AR, Yasar AS, et al. Impaired coronary blood flow in patients with metabolic syndrome: documented by thrombolysis in myocardial infarction (TIMI) frame count method. Am Heart J. 2004;148(5):789–794.
  • Sun H, Fukumoto Y, Ito A, et al. Coronary microvascular dysfunction in patients with microvascular angina: analysis by TIMI frame count. J Cardiovasc Pharmacol. 2005;46(5):622–626.
  • Beltrame JF. Defining the coronary slow flow phenomenon. Circ J. 2012;76(4):818–820.
  • Yin J, Wang S, Liu Y, et al. Coronary microvascular dysfunction pathophysiology in COVID-19. Microcirculation. 2021;28(7):e12718.
  • Cerqueira MD, Weissman NJ, Dilsizian V, American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. Circulation. 2002;105(4):539–542.
  • Czaja M, Wygoda Z, Duszańska A, et al. Interpreting myocardial perfusion scintigraphy using single-photon emission computed tomography. Part 1. Kardiochir Torakochirurgia Pol. 2017;14(3):192–199.
  • Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666–1687.
  • Peiris S, Mesa H, Aysola A, et al. Pathological findings in organs and tissues of patients with COVID-19: a systematic review. PLOS One. 2021;16(4):e0250708.
  • Monteil V, Kwon H, Prado P, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181(4):905–913.e7.
  • Debuc B, Smadja DM. Is COVID-19 a new hematologic disease? Stem Cell Rev Rep. 2021;17(1):4–8.
  • Henry BM, Vikse J, Benoit S, et al. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020;507:167–173.
  • Lala A, Johnson KW, Januzzi JL, et al. Mount Sinai COVID informatics center. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. 2020;76(5):533–546.
  • Fardman A, Oren D, Berkovitch A, et al. Post COVID-19 acute myocardial infarction rebound. Can J Cardiol. 2020;36(11):1832.e15–e16.
  • Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(21):2625–2641.
  • Kim HJ, Hong MK, Kim SH, et al. Evaluation of microvascular angina with TIMI frame count using nitroprusside induced hyperemia. Microvasc Res. 2013;87:95–99.
  • Faile BA, Guzzo JA, Tate DA, et al. Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow. Am Heart J. 2000;140(2):308–314.
  • Erbay AR, Turhan H, Senen K, et al. Documentation of slow coronary flow by the thrombolysis in myocardial infarction frame count in habitual smokers with angiographically normal coronary arteries. Heart Vessels. 2004;19(6):271–274.
  • Petersen JW, Johnson BD, Kip KE, et al. TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE). PLOS One. 2014;9(5):e96630.
  • Bybee KA, Prasad A, Barsness GW, et al. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004;94(3):343–346.
  • Wang X, Nie SP. The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovasc Diagn Ther. 2011;1(1):37–43.
  • Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605.
  • Lambadiari V, Mitrakou A, Kountouri A, et al. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection. Eur J Heart Fail. 2021;23(11):1916–1926.
  • Vallejo N, Teis A, Mateu L, et al. Persistent chest pain after recovery of COVID-19: microvascular disease-related angina? Eur Heart J Case Rep. 2021;5(3):ytab105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.